Latest News in the pharma Industry

Top Stories

Evotec and Roche Ink Biomarker Oncology Pact

Evotec and Roche Ink Biomarker Oncology Pact

27 Jun 2011

Under the initial three-year term, Evotec and Roche will conduct multiple biomarker programs for therapeutic antibodies or small molecule inhibitors.

Read more 
BioMarin To Acquire Pfizer Bulk Biologics Plant

BioMarin To Acquire Pfizer Bulk Biologics Plant

27 Jun 2011

BioMarin will acquire a bulk biologics manufacturing plant from Pfizer for $48.5 million. The deal is expected to close around September.

Read more 
Boehringer Ingelheim and Ashoka to Launch 'Making More Health' Initiative

Boehringer Ingelheim and Ashoka to Launch 'Making More Health' Initiative

27 Jun 2011

The initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenge health problems.

Read more 
Fujifilm and Mitsubishi in Bio-CMO Pact

Fujifilm and Mitsubishi in Bio-CMO Pact

24 Jun 2011

Fujifilm and Mitsubishi have signed an agreement for biopharma contract manufacturing.

Read more 
Endo Pharma Acquires AMS for $2.9Bn

Endo Pharma Acquires AMS for $2.9Bn

24 Jun 2011

Endo Pharmaceuticals Holdings Inc. said Monday it completed its $2.9 billion purchase of American Medical Systems Inc., a leading pelvic-health device provider.

Read more 
Australia to Subsidise 13 New Drugs

Australia to Subsidise 13 New Drugs

24 Jun 2011

More than 400,000 Australians will benefit from 13 subsidised medicines from September.

Read more 
Sanofi Inks Research Deal with Audion

Sanofi Inks Research Deal with Audion

20 Jun 2011

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

Read more 
Lundbeck to Submit Alcoholism Drug for European Approval

Lundbeck to Submit Alcoholism Drug for European Approval

20 Jun 2011

Lundbeck expects to file its alcoholism drug nalmefene in Europe following positive results from the final trial in the drug's Phase III clinical programme.

Read more 
UNCTAD: Developing Countries Have Opportunity to Attract Pharma Investment

UNCTAD: Developing Countries Have Opportunity to Attract Pharma Investment

20 Jun 2011

A report says the poorest countries in the world have an unprecedented opportunity to attract investment in the pharmaceutical sector.

Read more 
Janssen Recalls Risperdal Tablets and Risperidone Tablets

Janssen Recalls Risperdal Tablets and Risperidone Tablets

20 Jun 2011

The recalls stem from two consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA.

Read more 
Boehringer Ingelheim Signs Deal with Zealand

Boehringer Ingelheim Signs Deal with Zealand

20 Jun 2011

The agreement gives Boehringer Ingelheim global development and commercialisation rights to ZP2929, Zealand Pharma's lead glucagon/GLP-1 dual agonist drug candidate.

Read more 
Takeda Filed Actos Patent Litigations Against Generic Companies in Japan

Takeda Filed Actos Patent Litigations Against Generic Companies in Japan

20 Jun 2011

Takeda claims patent infringement by the 18 defendants companies and seeks provisional injunctions to prevent them from infringing its patents by manufacturing and selling generic products of ACTOS.

Read more